| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
FLT4 |
VEGFR3 long form |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CRK |
CRK: Proto-oncogene C-crk |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
0.535 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
0.535 |
Evidence |
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
FLT4 |
VEGFR3 long form |
0.535 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
0.535 |
Evidence |
|
| SPAG6 |
SPAG6, PF16: Sperm-associated antigen 6 |
FAT4 |
FATJ, FAT4: FAT tumor suppressor homolog 4 |
0.535 |
Evidence |
|
| SPAG6 |
SPAG6, PF16: Sperm-associated antigen 6 |
PCDH1 |
PCDH1: Protocadherin-1 precursor |
0.535 |
Evidence |
|
| DNAJC13 |
DNAJC13, KIAA0678, RME8: DnaJ homolog subfamily C member 13 |
FAT4 |
FATJ, FAT4: FAT tumor suppressor homolog 4 |
0.535 |
Evidence |
|
| MITF |
IPI00023896 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
0.535 |
Evidence |
|
| MITF |
IPI00023896 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
0.535 |
Evidence |
|
| MITF |
IPI00023896 |
HES6 |
HES6: Transcription cofactor HES-6 |
0.535 |
Evidence |
|
| MITF |
IPI00023896 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
0.535 |
Evidence |
|
| MITF |
IPI00023896 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
0.535 |
Evidence |
|